These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36154601)

  • 21. The evolution of peptide deformylase as a target: contribution of biochemistry, genetics and genomics.
    Yuan Z; White RJ
    Biochem Pharmacol; 2006 Mar; 71(7):1042-7. PubMed ID: 16289392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding affinities and geometries of various metal ligands in peptide deformylase inhibitors.
    Madison V; Duca J; Bennett F; Bohanon S; Cooper A; Chu M; Desai J; Girijavallabhan V; Hare R; Hruza A; Hendrata S; Huang Y; Kravec C; Malcolm B; McCormick J; Miesel L; Ramanathan L; Reichert P; Saksena A; Wang J; Weber PC; Zhu H; Fischmann T
    Biophys Chem; 2002 Dec; 101-102():239-47. PubMed ID: 12488004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular docking and molecular dynamics simulation approach to screen natural compounds for inhibition of
    Joshi T; Joshi T; Sharma P; Chandra S; Pande V
    J Biomol Struct Dyn; 2021 Feb; 39(3):823-840. PubMed ID: 31965918
    [No Abstract]   [Full Text] [Related]  

  • 24. Crystallization and preliminary X-ray crystallographic analysis of peptide deformylase (PDF) from Bacillus cereus in ligand-free and actinonin-bound forms.
    Park JK; Moon JH; Kim JH; Kim EE
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Jan; 61(Pt 1):150-2. PubMed ID: 16508119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy.
    Fu H; Dahlgren C; Bylund J
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2545-50. PubMed ID: 12878517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase.
    Grant SK; Green BG; Kozarich JW
    Bioorg Chem; 2001 Aug; 29(4):211-22. PubMed ID: 16256693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New peptide deformylase inhibitors and cooperative interaction: a combination to improve antibacterial activity.
    Goemaere E; Melet A; Larue V; Lieutaud A; Alves de Sousa R; Chevalier J; Yimga-Djapa L; Giglione C; Huguet F; Alimi M; Meinnel T; Dardel F; Artaud I; Pagès JM
    J Antimicrob Chemother; 2012 Jun; 67(6):1392-400. PubMed ID: 22378679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptide deformylase as an antibacterial drug target: target validation and resistance development.
    Apfel CM; Locher H; Evers S; Takács B; Hubschwerlen C; Pirson W; Page MG; Keck W
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1058-64. PubMed ID: 11257016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide deformylase: a new target in antibacterial, antimalarial and anticancer drug discovery.
    Sangshetti JN; Khan FA; Shinde DB
    Curr Med Chem; 2015; 22(2):214-36. PubMed ID: 25174923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structures of Staphylococcus aureus peptide deformylase in complex with two classes of new inhibitors.
    Lee SJ; Lee SJ; Lee SK; Yoon HJ; Lee HH; Kim KK; Lee BJ; Lee BI; Suh SW
    Acta Crystallogr D Biol Crystallogr; 2012 Jul; 68(Pt 7):784-93. PubMed ID: 22751663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide deformylases from Vibrio parahaemolyticus phage and bacteria display similar deformylase activity and inhibitor binding clefts.
    Grzela R; Nusbaum J; Fieulaine S; Lavecchia F; Desmadril M; Nhiri N; Van Dorsselaer A; Cianferani S; Jacquet E; Meinnel T; Giglione C
    Biochim Biophys Acta Proteins Proteom; 2018 Feb; 1866(2):348-355. PubMed ID: 29101077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.
    Hu X; Nguyen KT; Jiang VC; Lofland D; Moser HE; Pei D
    J Med Chem; 2004 Sep; 47(20):4941-9. PubMed ID: 15369398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational bioprospecting of phytoconstituents as potential inhibitors for peptide deformylase from Streptococcus oralis: An opportunistic pathogen.
    Sharma S; Pandey KM
    Arch Biochem Biophys; 2024 Aug; 758():110079. PubMed ID: 38969195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The crystal structures of four peptide deformylases bound to the antibiotic actinonin reveal two distinct types: a platform for the structure-based design of antibacterial agents.
    Guilloteau JP; Mathieu M; Giglione C; Blanc V; Dupuy A; Chevrier M; Gil P; Famechon A; Meinnel T; Mikol V
    J Mol Biol; 2002 Jul; 320(5):951-62. PubMed ID: 12126617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial Peptide deformylase inhibition of cyano substituted biaryl analogs: Synthesis, in vitro biological evaluation, molecular docking study and in silico ADME prediction.
    Khan FA; Patil RH; Shinde DB; Sangshetti JN
    Bioorg Med Chem; 2016 Aug; 24(16):3456-63. PubMed ID: 27269198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and synthesis of 4'-((5-benzylidene-2,4-dioxothiazolidin-3-yl)methyl)biphenyl-2-carbonitrile analogs as bacterial peptide deformylase inhibitors.
    Khan FA; Patil RH; Shinde DB; Sangshetti JN
    Chem Biol Drug Des; 2016 Dec; 88(6):938-944. PubMed ID: 27401234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deformylation of nascent peptide chains on the ribosome.
    Bögeholz LAK; Mercier E; Wintermeyer W; Rodnina MV
    Methods Enzymol; 2023; 684():39-70. PubMed ID: 37230593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structures of E. coli peptide deformylase bound to formate: insight into the preference for Fe2+ over Zn2+ as the active site metal.
    Jain R; Hao B; Liu RP; Chan MK
    J Am Chem Soc; 2005 Apr; 127(13):4558-9. PubMed ID: 15796505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity.
    Hackbarth CJ; Chen DZ; Lewis JG; Clark K; Mangold JB; Cramer JA; Margolis PS; Wang W; Koehn J; Wu C; Lopez S; Withers G; Gu H; Dunn E; Kulathila R; Pan SH; Porter WL; Jacobs J; Trias J; Patel DV; Weidmann B; White RJ; Yuan Z
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2752-64. PubMed ID: 12183225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide deformylase inhibitors with retro-amide scaffold: synthesis and structure-activity relationships.
    Lee SK; Choi KH; Lee SJ; Suh SW; Kim BM; Lee BJ
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4317-9. PubMed ID: 20615695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.